Castration Resistant Prostatic Neoplasms Terminated Phase 3 Trials for Tasquinimod (DB05861)
Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant
| Indication | Status | Phase |
|---|---|---|
| DBCOND0129140 (Castration Resistant Prostatic Neoplasms) | Terminated | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02057666 | Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer | Treatment |